| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.0055 | 1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |